Registered Zambia · ZAMRA

Iroflox Liquid Injection 50ml

ENROFLOXACININJECTION 10% W/V

ZAMRA-VM-25-328 Solution for Injection

What it does

Enrofloxacin is an antibiotic used to treat bacterial infections.

Commonly used for: bacterial infections, infections in pets (veterinary use)

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
ZAMRA-VM-25-328
Registration date
2025-09-15
Expiry date
2030-09-14
Status
Registered/Compliant
Active ingredient
ENROFLOXACININJECTION 10% W/V
Strength
-
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Intracin Pharmaceuticals
Country of origin
Zambia

Source: Zambia Medicines Regulatory Authority · fetched 2026-03-12 00:02:19 · updated 2026-09-17 03:34:05

Disclaimer: This information is sourced from Zambia Medicines Regulatory Authority (Zambia). Always consult a qualified healthcare professional before using any medication.

About this medicine

Enrofloxacin is an antibiotic used to treat bacterial infections.

What it treats

  • bacterial infections
  • infections in pets (veterinary use)

How it works

It works by stopping the growth of bacteria that cause infections.

Who it's for

This medication is mainly for animals, such as pets, suffering from bacterial infections.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: enrofloxacininjection

Enrofloxacin is a fluoroquinolone antibiotic that is primarily used in veterinary medicine. It is known for its broad-spectrum activity against both Gram-positive and Gram-negative bacteria, making it effective in treating various infections. Enrofloxacin is particularly noted for its use in small animals and livestock, where it can be administered via injection for rapid therapeutic effect.

Indications

  • Bacterial infections
  • Respiratory tract infections
  • Urinary tract infections
  • Skin infections
  • Gastrointestinal infections

Dosage

Children: Refer to specific veterinary guidelines or the BNF for appropriate dosing information.

Adults: Refer to specific veterinary guidelines or the BNF for appropriate dosing information.

Mechanism of action

Enrofloxacin works by inhibiting bacterial DNA gyrase and topoisomerase IV, which are essential enzymes for bacterial DNA replication, transcription, and repair. By disrupting these processes, enrofloxacin prevents bacterial cell division and ultimately leads to cell death.

Pharmacodynamics

Enrofloxacin exhibits concentration-dependent bactericidal activity, meaning that its effectiveness increases with higher drug concentrations. It has a post-antibiotic effect, allowing for continued suppression of bacterial growth even after drug levels have fallen below the minimum inhibitory concentration (MIC). Its spectrum of activity includes a variety of pathogens, including Escherichia coli, Salmonella, and Staphylococcus species.

Pharmacokinetics

After administration, enrofloxacin is rapidly absorbed and reaches peak plasma concentrations within 1 to 2 hours. It has a bioavailability of approximately 80-100%. The drug is widely distributed in body tissues and fluids, including the lungs, kidneys, and liver. Enrofloxacin is metabolized primarily in the liver and is excreted through the kidneys and bile, with a half-life of about 5 to 7 hours in most species.

Contra-indications

  • Hypersensitivity to enrofloxacin or other fluoroquinolones
  • Tendon disorders related to fluoroquinolone treatment
  • Severe renal impairment

Adverse effects

  • Gastrointestinal disturbances (nausea, vomiting, diarrhea)
  • Central nervous system effects (seizures, dizziness, headache)
  • Tendon rupture or tendinopathy, especially in older patients
  • Cartilage damage in growing animals (in veterinary use)
  • Photosensitivity reactions

Interactions

  • Antacids containing magnesium or aluminum may reduce absorption
  • Nonsteroidal anti-inflammatory drugs (NSAIDs) may increase the risk of CNS stimulation
  • Warfarin may have enhanced anticoagulant effect when used with enrofloxacin

Precautions

  • Use with caution in patients with a history of seizures
  • Monitor renal function during treatment
  • Avoid use in young animals due to potential cartilage damage
  • Consider alternative antibiotics in cases of severe infections

Pregnancy

Enrofloxacin is contraindicated during pregnancy due to potential harm to the fetus.

Breast-feeding

Use with caution in breastfeeding animals, as enrofloxacin can be excreted in milk.

Storage

Store at room temperature, away from light and moisture. Do not freeze.

Formulations

  • Injectable solution for veterinary use
  • Oral tablets for veterinary use

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.